valine has been researched along with Carcinoma, Medullary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camacho, CP; Cunha, LL; Dias-da-Silva, MR; Dotto, RP; Furuzawa, GK; Kasamatsu, TS; Kunii, IS; Lindsey, SC; Machado, AL; Maciel, RM; Martins, JR; Martins, MM; Martins-Costa, MC; Sousa, MS | 1 |
Anaganti, S; Billaud, M; Carlomagno, F; Fusco, A; Guida, T; Ryan, AJ; Santoro, M; Vecchio, G | 1 |
Cascone, E; Colantuoni, V; Fattoruso, O; Libroia, A; Lupoli, G; Quadro, L; Verga, U | 1 |
3 other study(ies) available for valine and Carcinoma, Medullary
Article | Year |
---|---|
M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
Topics: Adolescent; Adult; Aged, 80 and over; Amino Acid Substitution; Brazil; Carcinoma, Medullary; Child; Family; Female; Founder Effect; Germ-Line Mutation; Humans; Male; Methionine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation, Missense; Pedigree; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Valine; Young Adult | 2016 |
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.
Topics: Carcinoma, Medullary; Catalytic Domain; Cell Line; Drug Resistance; Enzyme Inhibitors; Mitogens; Piperidines; Point Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Pyrazoles; Pyrimidines; Quinazolines; Receptor Protein-Tyrosine Kinases; Signal Transduction; Thyroid Neoplasms; Valine | 2004 |
A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
Topics: Adult; Aged; Amino Acid Substitution; Carcinoma, Medullary; Codon; Deoxyribonucleases, Type II Site-Specific; DNA, Neoplasm; Drosophila Proteins; Exons; Family Health; Female; Humans; Male; Methionine; Pedigree; Point Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Valine | 1998 |